Concomitance of numerical chromosomal alterations with structural in an elderly with Alzheimer’s disease: a case report

Kledson Moraes Nunes, Talísia Nascimento Vianez, Denise Corrêa Benzaquem, Natalia Dayane Moura Carvalho, Cleiton Fantin


AIMS: To report the first case the concomitance of numerical chromosomal abnormalities with structural as well as chromosomal abnormalities structural in a patient diagnosed with Alzheimer disease in Manaus/Amazonas.
CASE DESCRIPTION: A male patient with 76 years of age was diagnosed with diagnosis of cognitive disorder- Alzheimer’s disease with late onset - temporal variant after laboratory, physical and imaging exams. Cytogenetic analysis was requested for this patient, revealing the presence the concomitant of numerical and structural chromosomal abnormalities with metaphase cells composed of 45 chromosomes with the loss of one of the homologues of chromosome 21 (monosomy) and a deletion of the long arm of one of the homologues of chromosome 1 [45, XY, -21, del (1) (q?)] and metaphase cells containing 46 chromosomes with a deletion of the long arm of one of the homologues of chromosome 15 [(46, XY, del (15) (q?)]. Currently, the patient is in outpatient treatment for maintenance and control of the disease.
CONCLUSIONS: Our study has underlined that karyotyping is one of the fundamental investigations for patients with Alzheimer’s disease. It highlighted, in the form of a chromosomal abnormality, may have been the risk factor in Alzheimer’s disease.


Autosomal chromosomes, X chromosome, cytogenetics.

Full Text:



Morley JE, Farr AS, Nguyen AD. Alzheimer Disease. Clin Geriatr Med. 2018;34(4):591-601.

Barranco-Quintana L, Allam F, Del Castillo S, Navajas F. Risk factors for Alzheimer’s disease. Rev Neurol. 2005;40(10):613-18.

Sochocka M, Zwolińska K, Leszek J. The infectious etiology of alzheimer’s disease. Curr Neuropharmacol. 2017;15(7):996-1009.

Ashraf GM, Tarasov VV, Makhmutovа A, Chubarev VN, Avila-Rodriguez M, Bachurin SO, Aliev G. The possibility of an infectious etiology of alzheimer disease. Mol Neurobiol. 2019;56(6):4479-91.

Ahmad MH, Fatima M, Mondal AC. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: rational insights for the therapeutic approaches. J Clin Neurosc. 2018;59:6-11.

Bettens K, Sleegers K, and Broeckhoven CV. Genetic insights in Alzheimer’s disease. Lancet. 2013;12(1):92-104.

Ward BE, Cook RH, Robinson A, Austin JH. Increased aneuploidy in Alzheimer disease. Am J Med Genet A. 1979;3(2):137-44.

White BJ, Crandall C, Goudsmit J, Morrow CH, Alling DW, Gajdusek DC. Cytogenetic studies of familial and sporadic Alzheimer disease. Am J Med Genet A. 1981;10(1):77-89.

Buckton KE, Whalley LJ, Lee M, Christie JE. Chromosome changes in Alzheimer’s presenile dementia. J Med Genet. 1983;20(1):46-51.

Iourov IY, Vorsanova SG, Liehr T, Yurov YB. Aneuploidy in the normal, Alzheimer’s disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol Dis. 2009;34(2):212-20.

Yurov YB, Vorsanova SG, Liehr T, Kolotii AD, Iourov IY. X chromosome aneuploidy in the Alzheimer’s disease brain. Mol Cytogenet. 2014;7(1):7-20.

Truzzi A, Laks J. Doença de Alzheimer esporádica de início precoce. Rev Psiq Clin. 2005;32(1):43-6.

Nordensson I, Beckman G, Adolfsson R, Bucht G, Winblad B. Cytogenetic changes in patients with senile dementia. Age Ageing. 1983;12(4):285 95.

Masarweh M. Chromosome 3q29 deletion with gastrointestinal malformation: a case report. J Med Case Rep. 2011;5(5):285-7.

Jhang KM, Chang TM, Chen M, Liu CS. Generalized epilepsy in a patient with mosaic Turner syndrome: a case report. J Med Case Rep. 2014;2(8):109-12.

Smith MAC. Doença de Alzheimer. Rev Bras Psiquiatr. 1999;21(2):1-5.

Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, De Stafano AL, Bis JC, Beecham GW. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45(12):1452-58.

Karch CM, Ezerskiy LA, Bertelsen S; Alzheimer’s Disease Genetics Consortium (ADGC) Goate AM. Alzheimer’s disease risk polymorphisms regulate gene expression in the ZCWPW1 and the CELF1 loci. PLoS One. 2016;11(2):e0148717.

Geller LN, Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer’s disease. Neurobiol Dis. 1999;6(3):167-79.

Bajic VP, Spremo-Potparevic B, Zivkovic L, Bonda DJ, Siedlak SL, Casadesus G, Lee HG, Smith MA. The X-chromosome instability phenotype in Alzheimer’s disease: A clinical sign of accelerating aging? Med Hypotheses. 2009;73(6):917-20.

Bajic V, Mandusic V, Stefanova E, Bozovic A, Davidovic R, Zivkovic L, Cabarkapa A, Spremo-Potparevic B. Skewed X-chromosome inactivation in women affected by Alzheimer’s disease. J Alzheimers Dis. 2015;43(4):1251-59.


e-ISSN: 1980-6108 | ISSN-L: 1806-5562

Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.